The present invention relates to a wearable thorax percussion device.
Cystic fibrosis (CF) is a hereditary chronic disease affecting human patients that causes the buildup of thick, sticky mucous in the lungs and other parts of the body. If left untreated, the mucous can clog air ways, and lead to complications such as tissue inflammation or infection, or other symptoms such as coughing, phlegm, and compromised cardio-respiratory performance.
One technique to manage CF is chest physiotherapy (CPT), which involves the manipulation of the patient's thorax to dislodge mucous buildup in the airways and encourage expectoration of the mucous. CPT may have to be performed in several sessions in a day, with each session lasting from between 10 to 45 minutes. CPT can be performed manually by therapists who use their hands to repeatedly percuss the patient's thorax. However, manually performed CPT can be physically and time demanding and should only be performed by a properly trained therapist. Alternatively, CPT can be performed using handheld or wearable mechanical devices. Wearable devices have the advantage over handheld devices of relieving the therapist or patient from having to manipulate the device during the treatment session.
Some wearable devices administer pulsating pneumatic pressure to the patient, U.S. Pat. No. 4,838,263 to Warwick et al, describes a vest bladder containing an air chamber and a pressurizing means to alternately pressurize and depressurize the air chamber to produce a pulsating compression on the patient's thorax, U.S. Pat. No. 6,036,662 to Van Brunt et al. describes a vest containing an air bladder that converts pulses of air into compressions to the patient's thorax. US Pat. Application No. 2005/0234372 to Hansen et al. describes a vest with an internal air chamber for receiving repeated pulses of air, which translate through the vest as pressure pulses against the patient's thorax. However, these devices rely on intimate contact between the vest and the patient's thorax and tend act over a relatively large area of the patient's thorax, with the result that they may constrict the patient's normal breathing motions.
Some wearable devices sonically transmit pressure waves to the patient generated by an acoustic transducer. U.S. Pat. No. 6,193,677 to Cady describes a vest incorporating a speaker to deliver low frequency pulsed audio signals to the patient, U.S. Pat. No. 6,193,677 to Plante describes a vest with a plurality of pockets or a harness-type arrangement to support an acoustic transducer to propagate acoustic waves via an acoustic coupling chamber to the patient. US Pat. Application No. 2008/0108914 to Brouqueyre et al, describes a vest with a vibration unit to transmit low frequency acoustic waves through a form-fitting material like a gel or fluid contained in the inner surface of the vest. However, transmission of pressure waves through a compressible medium may not be as efficacious as direct mechanical manipulation of the patient's thorax.
Some wearable devices administer mechanical impacts or vibrations to the patient. U.S. Pat. No. 3,310,050 to Goldfarb describes a vest-like garment or harness-type arrangement with a plurality of pockets to support a plurality of electro-mechanical vibrators to produce pulsating impacts that are communicated to the patient either by direct contact with the patient or indirectly through coupling constituted by the vest material and webbing belts. U.S. Pat. No. 5,235,967 to Arbisi et al, describes a vest-like garment with an internalized frame continuous throughout the garment, containing a plurality of movable electrically conductive elements that are actuated by a pulsed magnetic field produced by drive coils that are energized by a drive circuit. U.S. Pat. No. 5,261,394 to Mulligan et al. describes a percussive aid comprising arms that are reciprocally driven between a cocked position and a contact position by a drive mechanism, within a frame curved to fit the patient and adapted to be worn like a backpack, secured to the patient's thorax by shoulder and waist straps. US Pat. Appl. No. 2006/0089575 to DeVlieger describes a rigid element with pads clamped to the body, which transmit vibrations from an attached vibrator. The effectiveness of such devices depends, in part, on the ability to maintain contact at the interface between the device and the patient.
Accordingly, there remains a need for a wearable thorax percussion device that provides for effective, comfortable, convenient and consistent treatment of the patient.
Embodiments of the device provide a mechanical means for CPT without the labour of a trained therapist. The device may be embodied in a form that is light weight, and ergonomically adapted to the anatomy of the thoracic region.
In one aspect, the invention may comprise a wearable thorax percussion device, the device comprising:
In one embodiment, the device may comprise a front frame element and a rear frame element, interconnected by a plurality of straps, at least one of which is elastic or adjustable, or elastic and adjustable. The front frame element may comprise two symmetrical halves disposed on opposite sides of a front fastener system. The rigid layer may be substantially rigid in a planar direction and flexible in a direction normal to the planar direction. The device may comprise a garment.
In one embodiment, each actuator may comprise an inner cap and an outer housing, enclosing an electromagnet and a permanent magnet, one of which reciprocates in response to the electrical signal.
In another aspect, the invention may comprise a wearable thorax percussion device comprising at least one electromechanical actuator, which comprises:
In the drawings, like elements are assigned like reference numerals. The drawings are not necessarily to scale, with the emphasis instead placed upon the principles of the present invention. Additionally, each of the embodiments depicted are but one of a number of possible arrangements utilizing the fundamental concepts of the present invention. The drawings are briefly described as follows:
The invention relates to a wearable thorax percussion device. When describing the present invention, all terms not defined herein have their common art-recognized meanings.
The term “thorax” as used herein means the region of the human body which lies between the head and the abdomen, which includes the thoracic cavity enclosing the lungs, trachea and bronchi or portions thereof.
In general terms, the invention comprises a wearable device comprising a front frame and a rear frame, each comprising a plurality of electromechanical actuators, and which are interconnected to form a wearable device. The frame members retain and position the actuators in desired locations adjacent a user's thorax. The elements of the device are intended to work in concert to provide a device that is wearable with relative comfort, while allowing the actuators to provide effective percussion to the thorax of a user.
In one embodiment, the device (10) comprises a front frame member (20) and a rear frame member (30). The front frame member may be split into two symmetrical portions, which permits the device to be put on over the shoulders of the user and fastened together in the front with a zipper or the like, as is shown in
In one embodiment, the front frame (20) is connected to the rear frame (30) by a plurality of flexible straps comprising, in one embodiment, shoulder straps (40) and side straps (50). The straps may be elastic and/or adjustable, using well known buckles or connectors. Elastic and/or adjustable straps may accommodate patients with different sizes and shapes, or patients with mild to severe kephosis, which is common in CF patients. The side straps are preferably elastic so as to accommodate expansion and contraction of the thorax due to normal breathing, which is typically in the order of about 2 to 6 inches change in circumference.
The actuators (60) are powered elements which cause percussive strikes against the body of the user. In one embodiment, the actuators comprise electromechanical actuators which reciprocate in a linear fashion. In one embodiment, the front frame member (20) comprises four actuators (60), each positioned in one of four quadrants of the user's thoracic area, each quadrant created by a vertical midline and a horizontal midline through the thorax. The lower actuators are positioned slightly further away from the vertical midline, approximating the shape of a user's lungs. The rear frame member (30) also comprises four actuators, similarly positioned on the user's back thoracic area.
In one embodiment, the device comprises a front left frame element (20A), a front right frame element (2013) and a single rear frame element (30). This split front frame (20) accommodates a device or garment having a front central closure, such as a full length zipper (25). The frame elements may be substantially rigid or semi-rigid as they function to maintain the device shape and retain and position the actuators when in use. In one embodiment, the frame members are flat, planar members, oriented to lay flat against the user, such that they are substantially rigid in the planar direction. Accordingly, the frame members rigidly position the actuators. However, the frame members do allow some flexibility in a direction normal to the planar direction, which allows the device to closely conform to the shape of the user's thorax.
Each frame element may define openings within which the actuators (60) are positioned and retained. In one embodiment, each frame element may define multiple or elongated openings (not shown), which allows adjustable positioning of the actuators within the frame element.
In one embodiment, each front frame element (20A, 20B) retains four actuators (60A-D) to percuss the front region of the thorax to the right and left of the sternum. The rear rigid element (30) retains four actuators (60E-H) to percuss the user's back, symmetrically about the spine. The number of actuators (60) and their positioning can be strategically selected. In general, the position of the actuators (60) relative to the sternum and the spine should preferably not change significantly with patients ranging from the 5th percentile to the 95th percentile, and as such a single size of frame element (30) with adjustable placement of actuators can be used by a large portion of the patient demographic population.
As seen in
The frame elements (20, 30) may comprise a rigid layer, manufactured from sheet materials that are light weight, and have sufficient stiffness, impact resistance and durability to retain the actuators (60) with repeated use, such as metals or thermoset or thermoplastic materials. Suitable materials include aluminum or other metals, varieties of plastics include ABS (acrylonitrile-butadienestyrene), polystyrene, high impact polystyrene (HIPS), and KYDEX™material, or composite materials such as fiberglass or carbon fiber.
The frame elements (20, 30) may be configured with cavities, fingers, apertures and other features to retain or permit access to the actuators (60), the controller and any wires or cables use to conduct power or control signals to the actuators. As shown in
In one embodiment, the frame elements are combined with at least one conformable layer (70) which is positioned on the side of the frame element facing the user's body. This layer provides some comfort for the user. The conformable layer may comprise an open-celled foam, which would also provide breathability and increased comfort.
In one embodiment, the frame elements comprise a multi-layer construction, with at least one rigid layer and at least one flexible layer. In one embodiment, the frame elements comprise a sandwich construction, with a flexible layer disposed between two rigid layers. As shown in
The multi-layered frame elements may be encased in a fabric sleeve, which preferably comprises a soft, flexible and breathable material.
The actuators require a power source, which may comprise rechargeable batteries, and an electronic controller for generating and modulating a signal for energizing the actuators. The power source and controller may be integrated into a module (not shown) connected to the device by wires. Alternatively, the module may be integrated into the device.
In an alternative embodiment, shown in
The vest-like garment (100) may comprise a variety of fasteners and adjustments to facilitate fitting the garment to the thorax and positioning the frames (120, 130) on the user when the garment is worn. The front portion of the garment (100) may open and close with hook and loop fasteners, or other conventional fasteners such as zippers, clips or buttons, to permit the patient to don the garment (100). Additionally, or alternatively, the garment may be made of an elastic material to permit the user to slip the garment on, or to adjust to individual body shapes, or both.
The garment is preferably constructed of a light-weight, flexible and elastic material to accommodate the contours of the thorax. The garment may separate the actuators (60) from the user to protect the user from pinch points of moving components or electronic components associated with the actuators (60). Alternatively, the garment may define openings through which the actuators may contact the user.
In one alternative embodiment, as shown in
In one embodiment, the fabric sleeve (92, 192) provides an aesthetically and tactilely pleasing interface for the frame elements (20, 30). The fabric sleeves may also have design features to selectively expose parts of the frame elements or the controller (170) for access by the patient. The fabric sleeve (92, 192) may itself comprise thin foam/fabric combinations. In one embodiment, the actuator (60) comprises a cap (200) at one end to provide an interface to percuss the thorax, and a housing (202) at the other end to attach to a frame element (20, 30). A screw (203) may be used to facilitate attachment. A permanent magnet (206) creates a magnetic field that permeates through the surrounding housing (202) and inner disc (204), which are made of non-permanent magnetic materials and separated by a magnetic gap.
An electromagnet (208) is created by a coil wrapped around a bobbin (210). When an electric current is passed through the coil, it produces a magnetic field opposite in direction to the magnetic field created by the permanent magnet (206). The interaction of the magnetic fields repels the electromagnet away from the permanent magnet, thereby actuating the attached cap (200). Thus, the actuator may be oscillated, causing percussive strikes against the user's thorax when in use. The bobbin (210) and cap (200) may have channels through which the coil leads can exit the actuator (60) without a stress point. The bobbin (210) may be constructed of a wear and temperature resistant material such as PPS (polyphenylene sulphide), ULTEMTM™polymer, or polysulfone thermoplastic polymers. The bobbin may also act as a bearing surface in the event that there are side loading forces. The coil may be constructed with multi-strand wires or wires covered by a silicone sheath. Wire gauges ranging between 22 g and 30 g are appropriate for this application. In one embodiment, the coil comprises 6 layers of 28 g wiring.
In one embodiment, the actuator (60) is compressible between the thorax and the frame element. Thus, the actuator (60) can be preloaded by pressing it against the thorax to better maintain positive contact between the cap (200) and the thorax. The actuator (60) is made compressible by springs (212) or other resilient compressible means. The springs (212) pass through apertures in the bobbin (210) and inner disc (204), connected at one end to the cap (200) using a washer (218) and bear at the other end on the magnet (206). An assembly of screws (214) and D-washers (216) retains the springs (212) to the inner disc (204).
In another embodiment, as shown in
One embodiment of the electronic controller (170), as shown in
In order to protect against current inrush from overwhelming the power supply and associated traces, the controller (170) may introduce a short delay, preferably in the order of about 0.01 to 0.5 millisecond, between the turn-on time of each actuator (60) or phase the actuators (60) with respect to each other. The amplifier (173) utilizes the signal from the signal generator (172) and power received by the power supply inlet (171) to supply a nominal current, which may be about 0.7 A RMS, to the actuator (60). The amplifier (173) may include circuitry to maintain a constant percussion force despite variations in the power supply, such as an H-bridge with each channel having a dedicated chip to compensate each channel, or to have the ability to attenuate or disable a particular channel, relative to the other channels.
In one embodiment, the controller (170) may include a variety of controls such as an on/off control to start or stop a prescribed treatment cycle, a pause control to temporarily stop the treatment cycle to allow for mucous clearance, a frequency control to adjust the rate at which the actuators (60) deliver percussive force, an amplitude control to adjust the amount of current applied to the actuators (60) in a given period, and a timer for the on/off functionality to ensure that the treatment cycle is completed while accounting for any pauses.
The frame elements (20, 30), actuators (60) and the controller (170) may be tuned to produce desired force specifications. In one embodiment, the actuators (60) have a force constant of approximately 1 to 30 lbs per Ampere and apply percussive forces to the thorax of within a reasonable range of 1 to 10 lbs, which is similar to the magnitude of forces applied by a therapist administering manual CPT. In one embodiment, the force imparted by each strike of the actuator may be about 5 lbs.
This application is a Continuation-In-Part of U.S. patent application Ser. No. 13/538,716 filed on Jun. 29, 2012 entitled “Wearable Thorax Percussion Device”, the contents of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1646590 | Mildenberg | Oct 1927 | A |
2486667 | Meister | Nov 1949 | A |
3053250 | Stubbs | Sep 1962 | A |
3291123 | Terauchi | Dec 1966 | A |
3310050 | Goldfarb | Mar 1967 | A |
3460531 | Gardner | Aug 1969 | A |
3802417 | Lang | Apr 1974 | A |
3955563 | Maione | May 1976 | A |
4069816 | Yamamura et al. | Jan 1978 | A |
4079733 | Denton et al. | Mar 1978 | A |
4098266 | Muchisky et al. | Jul 1978 | A |
4102334 | Muchisky | Jul 1978 | A |
4216766 | Duykers et al. | Aug 1980 | A |
4387708 | Davis | Jun 1983 | A |
4397306 | Weisfeldt et al. | Aug 1983 | A |
4453538 | Whitney | Jun 1984 | A |
4508107 | Strom et al. | Apr 1985 | A |
4512339 | McShirley | Apr 1985 | A |
4530349 | Metzger | Jul 1985 | A |
4624244 | Taheri | Nov 1986 | A |
4697580 | Terauchi | Oct 1987 | A |
4838263 | Warwick et al. | Jun 1989 | A |
4887594 | Siegel | Dec 1989 | A |
4977889 | Budd | Dec 1990 | A |
5018517 | Liardet | May 1991 | A |
5056505 | Warwick et al. | Oct 1991 | A |
5167226 | Laroche et al. | Dec 1992 | A |
5181504 | Ono et al. | Jan 1993 | A |
5235967 | Arbisi et al. | Aug 1993 | A |
5261394 | Mulligan et al. | Nov 1993 | A |
5334131 | Omandam et al. | Aug 1994 | A |
5451190 | Liardet | Sep 1995 | A |
5453081 | Hansen | Sep 1995 | A |
5455159 | Mulshine et al. | Oct 1995 | A |
5496262 | Johnson, Jr. et al. | Mar 1996 | A |
5569170 | Hansen | Oct 1996 | A |
5716131 | Breeding | Feb 1998 | A |
5738637 | Kelly et al. | Apr 1998 | A |
5769797 | Van Brunt et al. | Jun 1998 | A |
5769800 | Gelfand et al. | Jun 1998 | A |
5891062 | Schock et al. | Apr 1999 | A |
6022328 | Hailey | Feb 2000 | A |
6036662 | Van Brunt et al. | Mar 2000 | A |
6098222 | Hand et al. | Aug 2000 | A |
6174295 | Cantrell et al. | Jan 2001 | B1 |
6176235 | Benarrouch et al. | Jan 2001 | B1 |
6190337 | Nedwell | Feb 2001 | B1 |
6193677 | Cady | Feb 2001 | B1 |
6193678 | Brannon | Feb 2001 | B1 |
6254556 | Hansen et al. | Jul 2001 | B1 |
6290660 | Epps et al. | Sep 2001 | B1 |
6352518 | nee Wolf | Mar 2002 | B1 |
D456591 | Hansen | May 2002 | S |
D461897 | Hansen et al. | Aug 2002 | S |
6478755 | Young | Nov 2002 | B2 |
D469876 | Hansen et al. | Feb 2003 | S |
6547749 | Hansen | Apr 2003 | B2 |
D478989 | Hansen et al. | Aug 2003 | S |
6676614 | Hansen et al. | Jan 2004 | B1 |
6702769 | Fowler-Hawkins | Mar 2004 | B1 |
6736785 | Van Brunt | May 2004 | B1 |
6958047 | DeVlieger | Oct 2005 | B2 |
6984214 | Fowler-Hawkins | Jan 2006 | B2 |
7074200 | Lewis | Jul 2006 | B1 |
7128811 | Watanabe | Oct 2006 | B2 |
D531728 | Helgeson | Nov 2006 | S |
7207953 | Goicaj | Apr 2007 | B1 |
7232417 | Plante | Jun 2007 | B2 |
D547718 | Helgeson et al. | Jul 2007 | S |
7278978 | Hansen et al. | Oct 2007 | B1 |
7343916 | Biondo et al. | Mar 2008 | B2 |
7374500 | Engdahl | May 2008 | B2 |
7416536 | DeVlieger | Aug 2008 | B2 |
7445607 | Plante | Nov 2008 | B2 |
D585991 | Helgeson et al. | Feb 2009 | S |
7537575 | Hansen et al. | May 2009 | B2 |
7597670 | Warwick et al. | Oct 2009 | B2 |
7618384 | Nardi et al. | Nov 2009 | B2 |
7713219 | Helgeson et al. | May 2010 | B2 |
7736324 | Helgeson | Jun 2010 | B1 |
7762967 | Warwick et al. | Jul 2010 | B2 |
7785280 | Kivisto | Aug 2010 | B2 |
7927293 | Ignagni et al. | Apr 2011 | B1 |
7931607 | Biondo et al. | Apr 2011 | B2 |
D639954 | Helgeson et al. | Jun 2011 | S |
7981066 | Lewis | Jul 2011 | B2 |
8108957 | Richards et al. | Feb 2012 | B2 |
8192381 | Nozzarella | Jun 2012 | B2 |
8197428 | Helgeson et al. | Jun 2012 | B2 |
8202237 | Helgeson et al. | Jun 2012 | B2 |
8241233 | Litton et al. | Aug 2012 | B2 |
8257288 | Hansen et al. | Sep 2012 | B2 |
8273039 | Ignagni | Sep 2012 | B1 |
8460223 | Huster et al. | Jun 2013 | B2 |
8584279 | Richards et al. | Nov 2013 | B2 |
D697197 | Hansen et al. | Jan 2014 | S |
8734370 | Ignagni | May 2014 | B1 |
8777880 | Davis et al. | Jul 2014 | B2 |
8790285 | Bisera et al. | Jul 2014 | B2 |
8801643 | Deshpande et al. | Aug 2014 | B2 |
20020014235 | Rogers et al. | Feb 2002 | A1 |
20020016560 | Hansen | Feb 2002 | A1 |
20020111571 | Warwick et al. | Aug 2002 | A1 |
20020195144 | Hand et al. | Dec 2002 | A1 |
20040069304 | Jam | Apr 2004 | A1 |
20040097842 | Van Brunt et al. | May 2004 | A1 |
20040097843 | Van Brunt et al. | May 2004 | A1 |
20040097844 | Van Brunt et al. | May 2004 | A1 |
20040097845 | Van Brunt | May 2004 | A1 |
20040097846 | Van Brunt et al. | May 2004 | A1 |
20040097847 | Van Brunt et al. | May 2004 | A1 |
20040097849 | Van Brunt | May 2004 | A1 |
20040097850 | Plante | May 2004 | A1 |
20040133133 | Dreimann | Jul 2004 | A1 |
20040158177 | Van Brunt et al. | Aug 2004 | A1 |
20050150720 | Tudor | Jul 2005 | A1 |
20050234372 | Hansen et al. | Oct 2005 | A1 |
20050235988 | Hansen | Oct 2005 | A1 |
20060005306 | Call | Jan 2006 | A1 |
20060089575 | DeVlieger | Apr 2006 | A1 |
20080108914 | Brouqueyre et al. | May 2008 | A1 |
20080221489 | Madsen | Sep 2008 | A1 |
20080300515 | Nozzarella et al. | Dec 2008 | A1 |
20090069728 | Hoffmann | Mar 2009 | A1 |
20090221944 | Hobson | Sep 2009 | A1 |
20100113993 | Davis | May 2010 | A1 |
20100242955 | Hansen | Sep 2010 | A1 |
20100249634 | Hansen | Sep 2010 | A1 |
20110125068 | Hansen et al. | May 2011 | A1 |
20120067322 | Andersson | Mar 2012 | A1 |
20120291798 | Park | Nov 2012 | A1 |
20130261518 | Hansen et al. | Oct 2013 | A1 |
20130331747 | Helgeson et al. | Dec 2013 | A1 |
20140276271 | Stryker et al. | Sep 2014 | A1 |
Number | Date | Country |
---|---|---|
2563723 | Aug 2011 | CA |
1136896 | Dec 1968 | GB |
2 068 737 | Feb 1981 | GB |
2011094883 | Aug 2011 | WO |
Entry |
---|
International Biophysics Corporation—“AffloVest Answering Needs: The Role of the AffloVest in the Respiratory Market” AffloVest White Paper. |
The “VibraVest” by OxyCare GmbH, VibraVest—engl—web.pdf, Nov. 23, 2011 (3 pages). |
AffloVest Instructions for Use and Owner's Manual, AffloVest.com; document created Jun. 24, 2013 (18 pages). |
Clinical Study of the AffloVest, Mar. 2013 (6 pages). |
Rubin, Bruce K.; Emerging Therapies for Cystic Fibrosis Lung Disease; Chest; 1999; vol. 115; pp. 1120-1126. |
Number | Date | Country | |
---|---|---|---|
20140012167 A1 | Jan 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13538716 | Jun 2012 | US |
Child | 13930586 | US |